深康佳A(000016.SZ)完成轉讓東莞投資公司51%股權
格隆匯 9 月 25日丨深康佳A(000016.SZ)公佈,公司與深圳市宇宏榮基投資有限公司簽署的《產權交易合同》,公司於近日完成了東莞康佳投資有限公司(“東莞投資公司”)的工商變更登記,收到全部股權轉讓款,並按轉讓股權比例收回了2.04億元的股東借款。
東莞投資公司此次工商變更的主要內容為:
股東信息:由“康佳集團股份有限公司認繳出資額1億元,出資比例100%”變更為“深圳市宇宏榮基投資有限公司認繳出資額5100萬元,出資比例51%;康佳集團股份有限公司認繳出資額4900萬元,出資比例49%”。
企業類型:由“有限責任公司(法人獨資)”變更為“其他有限責任公司”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.